放射線毒性治療の世界市場レポート 2025年

放射線毒性治療市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR6.4%で51億2,000万米ドルに成長します。予測期間中の成長が期待される背景には、個別化医療アプローチの台頭、予防ヘルスケアの重視、外来医療サービスの需要拡大、放射線安全性に関する世界の啓発キャンペーンの増加、がん医療へのアクセス改善を目的とした政府イニシアチブの強化などがあります。予測期間における主な動向としては、治療計画における人工知能の統合、画像誘導放射線治療の主な発展、定位体放射線治療の開発、ナノ粒子ドラッグデリバリーシステムの革新、オーダーメイド治療ソリューションのための3Dプリンティングの利用などが挙げられます。

がん罹患率の上昇が放射線毒性治療市場の成長を牽引すると予想されます。がんとは、制御不能な異常細胞の増殖と拡散によって特徴づけられる疾患群を指し、この異常細胞は近隣の組織に侵入し、身体の他の部分に転移する可能性があります。ライフスタイルの変化、環境汚染、遺伝的素因、早期発見を可能にする診断技術の進歩などの要因が、がん発生率の増加に寄与しています。放射線毒性治療は、放射線治療の副作用を管理し、患者の回復を助け、長期的な害を減らす上で重要な役割を果たしています。例えば、2024年8月にマクミラン・キャンサー・サポートが発表した報告書によると、英国では300万人以上ががんと共に生活しており、その数は2025年までに350万人、2030年までに400万人、2040年までに530万人に増加すると予想されています。このように、がん罹患率の増加が放射線毒性治療市場の拡大に拍車をかけています。

放射線毒性治療市場の企業は、治療の精度と有効性を高めるため、特に先進ドラッグデリバリーシステムのイノベーションに注力しています。これらのシステムは、患者のコンプライアンスを向上させ、副作用を最小限に抑え、最終的にはより良い転帰と迅速な回復につなげることを目的としています。ドラッグデリバリーシステムは、薬物が適切な投与量で体内の標的部位に到達することを保証し、不要な影響を抑えながら有効性を高める。例えば、2023年12月、米国のバイオ医薬品会社であるコーヘラス・バイオサイエンシズ社は、ペグフィルグラスチム-cbqvの新しい体内注射器であるUDENYCA ONBODYの米国FDAによる承認を発表しました。この装置は、発熱性好中球減少症による感染症のリスクを軽減するために、化学療法の翌日に使用されます。この注射器は5分で薬剤を投与することができ、安全性と快適性を高めるために開閉可能な注射針を備えています。今回の承認により、コーヘラス社は、化学療法の副作用を管理するためのより便利でユーザーフレンドリーなソリューションを提供することを目指します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- マクロ経済シナリオ金利、インフレ、地政学、新型コロナウイルス感染症の影響と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界放射線毒性治療PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の放射線毒性治療市場：成長率分析
• 世界の放射線毒性治療市場の実績：規模と成長, 2019-2024
• 世界の放射線毒性治療市場の予測：規模と成長, 2024-2029, 2034F
• 世界放射線毒性治療総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の放射線毒性治療市場：製品別、実績と予測, 2019-2024, 2024-2029F, 2034F
• コロニー刺激因子
• ヨウ化カリウム
• プルシアンブルー
• ジエチレントリアミン五酢酸
• その他の製品
• 世界の放射線毒性治療市場：適応症別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 急性放射線症候群
• 慢性放射線症候群
• 世界の放射線毒性治療市場放射線の種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 電離放射線
• 非電離放射線
• 世界の放射線毒性治療市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 調査・学術機関
• 世界の放射線毒性治療市場コロニー刺激因子の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 顆粒球コロニー刺激因子（G-CSF）
• 顆粒球マクロファージコロニー刺激因子（GM-CSF）
• 世界の放射線毒性治療市場ヨウ化カリウムの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 経口ヨウ化カリウム錠
• 液体ヨウ化カリウム溶液
• 世界の放射線毒性治療市場プルシアンブルーの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• プルシアンブルーのカプセル
• プルシアンブルー樹脂
• 世界の放射線毒性治療市場ジエチレントリアミン五酢酸（DTPA）の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• DTPA注射（カルシウムおよび亜鉛DTPA）
• 世界の放射線毒性治療市場、その他の製品のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• アミフォスチン
• 重炭酸ナトリウム
• ドキシサイクリン
• 活性炭

第7章 地域別・国別分析

• 世界の放射線毒性治療市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の放射線毒性治療市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 放射線毒性治療市場：競合情勢
• 放射線毒性治療市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• AstraZeneca PLC
• Novartis AG
• Amgen Inc.
• Varian Medical Systems
• Recipharm AB
• Elekta AB
• Lantheus Medical Imaging Inc.
• Ion Beam Applications SA
• Accuray Incorporated
• Coherus BioSciences Inc.
• Eckert & Ziegler Strahlen-und Medizintechnik AG
• Theragenics Corp.
• NorthStar Medical Radioisotopes LLC
• Fusion Pharmaceuticals Inc.
• Blue Earth Diagnostics Ltd.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 放射線毒性治療市場2029：新たな機会を提供する国
• 放射線毒性治療市場2029：新たな機会を提供するセグメント
• 放射線毒性治療市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Radiation toxicity treatment involves medical strategies aimed at alleviating and reducing the harmful effects of excessive radiation exposure. These treatments focus on managing symptoms such as fatigue, nausea, and skin damage, as well as more severe issues such as organ or bone marrow damage, with the goal of supporting recovery and minimizing long-term health risks.

Key products in the radiation toxicity treatment market include colony stimulating factors, potassium iodide, prussian blue, diethylenetriamine pentaacetic acid, and others. Colony stimulating factors are biological agents that stimulate the production of blood cells by activating bone marrow. These substances play a vital role in restoring blood cell levels in conditions that cause low blood counts, such as during medical treatments. They are used to treat conditions such as acute and chronic radiation syndrome, addressing both ionizing and non-ionizing radiation types. These products are utilized in hospitals, as well as research and academic institutions.

The radiation toxicity treatment market research report is one of a series of new reports from The Business Research Company that provides radiation toxicity treatment market statistics, including the radiation toxicity treatment industry's global market size, regional shares, competitors with a radiation toxicity treatment market share, detailed radiation toxicity treatment market segments, market trends and opportunities, and any further data you may need to thrive in the radiation toxicity treatment industry. This radiation toxicity treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The radiation toxicity treatment market size has grown strongly in recent years. It will grow from $3.74 billion in 2024 to $3.99 billion in 2025 at a compound annual growth rate (CAGR) of 6.7%. The growth during the historical period can be attributed to the increasing global prevalence of cancer, a rising demand for radiotherapy as a treatment option, the expansion of healthcare infrastructure and facilities, a higher incidence of radiation exposure, and an increased awareness of radiation toxicity.

The radiation toxicity treatment market size is expected to see strong growth in the next few years. It will grow to $5.12 billion in 2029 at a compound annual growth rate (CAGR) of 6.4%. The expected growth in the forecast period is driven by the rise of personalized medicine approaches, a greater emphasis on preventive healthcare, a growing demand for outpatient care services, increased global awareness campaigns about radiation safety, and more government initiatives aimed at improving access to cancer care. Key trends in the forecast period include the integration of artificial intelligence in treatment planning, advancements in image-guided radiation therapy, the development of stereotactic body radiation therapy, innovations in nanoparticle drug delivery systems, and the use of 3D printing for customized treatment solutions.

The rising incidence of cancer is expected to drive the growth of the radiation toxicity treatment market. Cancer refers to a group of diseases marked by the uncontrolled growth and spread of abnormal cells that can invade nearby tissues and metastasize to other parts of the body. Factors such as lifestyle changes, environmental pollution, genetic predisposition, and advancements in diagnostic technologies, which enable earlier detection, contribute to the increasing cancer rates. Radiation toxicity treatment plays a crucial role in managing the side effects of radiation therapy, aiding patient recovery, and reducing long-term harm. For example, a report from Macmillan Cancer Support in August 2024 revealed that over 3 million people in the UK are living with cancer, a number expected to rise to 3.5 million by 2025, 4 million by 2030, and 5.3 million by 2040. As such, the growing cancer prevalence is fueling the expansion of the radiation toxicity treatment market.

Companies in the radiation toxicity treatment market are focusing on innovations, particularly in advanced drug delivery systems, to enhance the precision and effectiveness of treatments. These systems aim to improve patient compliance, minimize side effects, and ultimately lead to better outcomes and quicker recovery. A drug delivery system ensures that medication reaches targeted areas of the body in the right dosage, enhancing efficacy while limiting unwanted effects. For instance, in December 2023, Coherus BioSciences, a US-based biopharmaceutical firm, announced the U.S. FDA's approval of UDENYCA ONBODY, a new on-body injector for pegfilgrastim-cbqv. This device is used the day after chemotherapy to reduce the risk of infection from febrile neutropenia. The injector delivers the medication in five minutes and includes a retractable needle for greater safety and comfort. With this approval, Coherus aims to provide a more convenient and user-friendly solution for managing chemotherapy side effects.

In June 2024, AstraZeneca Plc, a UK-based pharmaceutical company, acquired Fusion Pharmaceuticals Inc. for $2.5 billion. This acquisition aims to strengthen AstraZeneca's oncology portfolio with advanced radiopharmaceuticals such as FPI-2265, enhance its research and development and manufacturing capabilities, and accelerate the transition toward targeted cancer therapies. It also deepens the company's presence in Canada. Fusion Pharmaceuticals, based in Canada, specializes in developing next-generation radiopharmaceuticals as precision treatments for oncology.

Major players in the radiation toxicity treatment market are Pfizer Inc., Merck & Co. Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis AG, Amgen Inc., Varian Medical Systems, Recipharm AB, Elekta AB, Lantheus Medical Imaging Inc., Ion Beam Applications SA, Accuray Incorporated, Coherus BioSciences Inc., Eckert & Ziegler Strahlen- und Medizintechnik AG, Theragenics Corp., NorthStar Medical Radioisotopes LLC, Fusion Pharmaceuticals Inc., Blue Earth Diagnostics Ltd., Partner Therapeutics Inc., Heyl Chemisch-pharmazeutische Fabrik GmbH & Co. KG, Humanetics Corporation, Actinium Pharmaceuticals Inc., and Clarity Pharmaceuticals Ltd.

North America was the largest region in the radiation toxicity treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in radiation toxicity treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the radiation toxicity treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The radiation toxicity treatment market includes revenues earned by entities by providing services such as blood transfusions, chelation therapy, skin care and burn management, cancer screening, pain management, and bone marrow protection. The market value includes the value of related goods sold by the service provider or included within the service offering. The radiation toxicity treatment market consists of sales of radiation detection and survey devices, personal dosimeters, linear accelerators (LINACs), and neutron capture therapy systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Radiation Toxicity Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on radiation toxicity treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for radiation toxicity treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The radiation toxicity treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Colony Stimulating Factors; Potassium Iodide; Prussian Blue; Diethylenetriamine Pentaacetic Acid; Others Products
• 2) By Indication: Acute Radiation Syndrome; Chronic Radiation Syndrome
• 3) By Radiation Type: Ionizing Radiation; Non-Ionizing Radiation
• 4) By End-User: Hospitals; Research And Academic Institutes
• Subsegments:
• 1) By Colony Stimulating Factors: Granulocyte Colony-Stimulating Factor (G-CSF); Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)
• 2) By Potassium Iodide: Oral Potassium Iodide Tablets; Liquid Potassium Iodide Solution
• 3) By Prussian Blue: Capsules Of Prussian Blue; Prussian Blue Resin
• 4) By Diethylenetriamine Pentaacetic Acid (DTPA): DTPA Injection (Calcium And Zinc DTPA)
• 5) By Other Products: Amifostine; Sodium Bicarbonate; Doxycycline; Activated Charcoal
• Companies Mentioned: Pfizer Inc.; Merck & Co. Inc.; Bayer AG; Sanofi S.A.; Bristol-Myers Squibb Company
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Radiation Toxicity Treatment Market Characteristics

3. Radiation Toxicity Treatment Market Trends And Strategies

4. Radiation Toxicity Treatment Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Radiation Toxicity Treatment Growth Analysis And Strategic Analysis Framework

• 5.1. Global Radiation Toxicity Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Radiation Toxicity Treatment Market Growth Rate Analysis
• 5.4. Global Radiation Toxicity Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Radiation Toxicity Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Radiation Toxicity Treatment Total Addressable Market (TAM)

6. Radiation Toxicity Treatment Market Segmentation

• 6.1. Global Radiation Toxicity Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Colony Stimulating Factors
• Potassium Iodide
• Prussian Blue
• Diethylenetriamine Pentaacetic Acid
• Others Products
• 6.2. Global Radiation Toxicity Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Acute Radiation Syndrome
• Chronic Radiation Syndrome
• 6.3. Global Radiation Toxicity Treatment Market, Segmentation By Radiation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Ionizing Radiation
• Non-Ionizing Radiation
• 6.4. Global Radiation Toxicity Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Research And Academic Institutes
• 6.5. Global Radiation Toxicity Treatment Market, Sub-Segmentation Of Colony Stimulating Factors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Granulocyte Colony-Stimulating Factor (G-CSF)
• Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)
• 6.6. Global Radiation Toxicity Treatment Market, Sub-Segmentation Of Potassium Iodide, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral Potassium Iodide Tablets
• Liquid Potassium Iodide Solution
• 6.7. Global Radiation Toxicity Treatment Market, Sub-Segmentation Of Prussian Blue, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Capsules Of Prussian Blue
• Prussian Blue Resin
• 6.8. Global Radiation Toxicity Treatment Market, Sub-Segmentation Of Diethylenetriamine Pentaacetic Acid (DTPA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• DTPA Injection (Calcium And Zinc DTPA)
• 6.9. Global Radiation Toxicity Treatment Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Amifostine
• Sodium Bicarbonate
• Doxycycline
• Activated Charcoal

7. Radiation Toxicity Treatment Market Regional And Country Analysis

• 7.1. Global Radiation Toxicity Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Radiation Toxicity Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Radiation Toxicity Treatment Market

• 8.1. Asia-Pacific Radiation Toxicity Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Radiation Toxicity Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Radiation Toxicity Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Radiation Toxicity Treatment Market, Segmentation By Radiation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Radiation Toxicity Treatment Market

• 9.1. China Radiation Toxicity Treatment Market Overview
• 9.2. China Radiation Toxicity Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Radiation Toxicity Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Radiation Toxicity Treatment Market, Segmentation By Radiation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Radiation Toxicity Treatment Market

• 10.1. India Radiation Toxicity Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Radiation Toxicity Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Radiation Toxicity Treatment Market, Segmentation By Radiation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Radiation Toxicity Treatment Market

• 11.1. Japan Radiation Toxicity Treatment Market Overview
• 11.2. Japan Radiation Toxicity Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Radiation Toxicity Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Radiation Toxicity Treatment Market, Segmentation By Radiation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Radiation Toxicity Treatment Market

• 12.1. Australia Radiation Toxicity Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Radiation Toxicity Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Radiation Toxicity Treatment Market, Segmentation By Radiation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Radiation Toxicity Treatment Market

• 13.1. Indonesia Radiation Toxicity Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Radiation Toxicity Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Radiation Toxicity Treatment Market, Segmentation By Radiation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Radiation Toxicity Treatment Market

• 14.1. South Korea Radiation Toxicity Treatment Market Overview
• 14.2. South Korea Radiation Toxicity Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Radiation Toxicity Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Radiation Toxicity Treatment Market, Segmentation By Radiation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Radiation Toxicity Treatment Market

• 15.1. Western Europe Radiation Toxicity Treatment Market Overview
• 15.2. Western Europe Radiation Toxicity Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Radiation Toxicity Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Radiation Toxicity Treatment Market, Segmentation By Radiation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Radiation Toxicity Treatment Market

• 16.1. UK Radiation Toxicity Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Radiation Toxicity Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Radiation Toxicity Treatment Market, Segmentation By Radiation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Radiation Toxicity Treatment Market

• 17.1. Germany Radiation Toxicity Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Radiation Toxicity Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Radiation Toxicity Treatment Market, Segmentation By Radiation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Radiation Toxicity Treatment Market

• 18.1. France Radiation Toxicity Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Radiation Toxicity Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Radiation Toxicity Treatment Market, Segmentation By Radiation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Radiation Toxicity Treatment Market

• 19.1. Italy Radiation Toxicity Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Radiation Toxicity Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Radiation Toxicity Treatment Market, Segmentation By Radiation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Radiation Toxicity Treatment Market

• 20.1. Spain Radiation Toxicity Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Radiation Toxicity Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Radiation Toxicity Treatment Market, Segmentation By Radiation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Radiation Toxicity Treatment Market

• 21.1. Eastern Europe Radiation Toxicity Treatment Market Overview
• 21.2. Eastern Europe Radiation Toxicity Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Radiation Toxicity Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Radiation Toxicity Treatment Market, Segmentation By Radiation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Radiation Toxicity Treatment Market

• 22.1. Russia Radiation Toxicity Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Radiation Toxicity Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Radiation Toxicity Treatment Market, Segmentation By Radiation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Radiation Toxicity Treatment Market

• 23.1. North America Radiation Toxicity Treatment Market Overview
• 23.2. North America Radiation Toxicity Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Radiation Toxicity Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Radiation Toxicity Treatment Market, Segmentation By Radiation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Radiation Toxicity Treatment Market

• 24.1. USA Radiation Toxicity Treatment Market Overview
• 24.2. USA Radiation Toxicity Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Radiation Toxicity Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Radiation Toxicity Treatment Market, Segmentation By Radiation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Radiation Toxicity Treatment Market

• 25.1. Canada Radiation Toxicity Treatment Market Overview
• 25.2. Canada Radiation Toxicity Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Radiation Toxicity Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Radiation Toxicity Treatment Market, Segmentation By Radiation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Radiation Toxicity Treatment Market

• 26.1. South America Radiation Toxicity Treatment Market Overview
• 26.2. South America Radiation Toxicity Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Radiation Toxicity Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Radiation Toxicity Treatment Market, Segmentation By Radiation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Radiation Toxicity Treatment Market

• 27.1. Brazil Radiation Toxicity Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Radiation Toxicity Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Radiation Toxicity Treatment Market, Segmentation By Radiation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Radiation Toxicity Treatment Market

• 28.1. Middle East Radiation Toxicity Treatment Market Overview
• 28.2. Middle East Radiation Toxicity Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Radiation Toxicity Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Radiation Toxicity Treatment Market, Segmentation By Radiation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Radiation Toxicity Treatment Market

• 29.1. Africa Radiation Toxicity Treatment Market Overview
• 29.2. Africa Radiation Toxicity Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Radiation Toxicity Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Radiation Toxicity Treatment Market, Segmentation By Radiation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Radiation Toxicity Treatment Market Competitive Landscape And Company Profiles

• 30.1. Radiation Toxicity Treatment Market Competitive Landscape
• 30.2. Radiation Toxicity Treatment Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

31. Radiation Toxicity Treatment Market Other Major And Innovative Companies

• 31.1. AstraZeneca PLC
• 31.2. Novartis AG
• 31.3. Amgen Inc.
• 31.4. Varian Medical Systems
• 31.5. Recipharm AB
• 31.6. Elekta AB
• 31.7. Lantheus Medical Imaging Inc.
• 31.8. Ion Beam Applications SA
• 31.9. Accuray Incorporated
• 31.10. Coherus BioSciences Inc.
• 31.11. Eckert & Ziegler Strahlen- und Medizintechnik AG
• 31.12. Theragenics Corp.
• 31.13. NorthStar Medical Radioisotopes LLC
• 31.14. Fusion Pharmaceuticals Inc.
• 31.15. Blue Earth Diagnostics Ltd.

32. Global Radiation Toxicity Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Radiation Toxicity Treatment Market

34. Recent Developments In The Radiation Toxicity Treatment Market

35. Radiation Toxicity Treatment Market High Potential Countries, Segments and Strategies

• 35.1 Radiation Toxicity Treatment Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Radiation Toxicity Treatment Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Radiation Toxicity Treatment Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer